日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A general esterolysis strategy for upcycling waste polyesters into high-value esters

一种将废弃聚酯升级再造成高价值酯的通用酯解策略

Zhang, Minghao; Yu, Yunkai; Han, Buxing; Mei, Qingqing

AAV-mediated inner ear gene delivery triggers mild host immune responses in the mammalian inner ear.

AAV介导的内耳基因递送可引发哺乳动物内耳中轻微的宿主免疫反应

Ishibashi Yasuko, Zhu Jianliang, Gernoux Gwladys, Yu Yunkai, Suh Michelle J, Isgrig Kevin, Grati Mhamed, Olszewski Rafal, Hoa Michael, Liang Cao, Friedman Thomas B, Adjali Oumeya, Chien Wade W

Tofacitinib to prevent anti-drug antibody formation against LMB-100 immunotoxin in patients with advanced mesothelin-expressing cancers.

托法替尼用于预防晚期间皮素表达癌症患者体内针对LMB-100免疫毒素的抗药抗体形成

Skorupan Nebojsa, Peer Cody J, Zhang Xianyu, Choo-Wosoba Hyoyoung, Ahmad Mehwish I, Lee Min-Jung, Rastogi Shraddha, Sato Nahoko, Yu Yunkai, Pegna Guillaume Joe, Steinberg Seth M, Kalsi Shelley S, Cao Liang, Figg William D, Trepel Jane B, Pastan Ira, FitzGerald David, Alewine Christine

Systemic immune changes accompany combination treatment with immunotoxin LMB-100 and nab-paclitaxel

免疫毒素LMB-100与白蛋白紫杉醇联合治疗会伴随全身免疫变化。

Pegna, Guillaume Joe; Lee, Min-Jung; Peer, Cody J; Ahmad, Mehwish I; Venzon, David J; Yu, Yunkai; Yuno, Akira; Steinberg, Seth M; Cao, Liang; Figg, William D; Donahue, Renee N; Hassan, Raffit; Pastan, Ira; Trepel, Jane B; Alewine, Christine

Cabozantinib plus Nivolumab Phase I Expansion Study in Patients with Metastatic Urothelial Carcinoma Refractory to Immune Checkpoint Inhibitor Therapy

卡博替尼联合纳武利尤单抗治疗对免疫检查点抑制剂疗法耐药的转移性尿路上皮癌患者的I期扩展研究

Girardi, Daniel M; Niglio, Scot A; Mortazavi, Amir; Nadal, Rosa; Lara, Primo; Pal, Sumanta K; Saraiya, Biren; Cordes, Lisa; Ley, Lisa; Ortiz, Olena Sierra; Cadena, Jacqueline; Diaz, Carlos; Bagheri, Hadi; Redd, Bernadette; Steinberg, Seth M; Costello, Rene; Chan, Keith S; Lee, Min-Jung; Lee, Sunmin; Yu, Yunkai; Gurram, Sandeep; Chalfin, Heather J; Valera, Vladimir; Figg, William D; Merino, Maria; Toubaji, Antoun; Streicher, Howard; Wright, John J; Sharon, Elad; Parnes, Howard L; Ning, Yang-Min; Bottaro, Donald P; Cao, Liang; Trepel, Jane B; Apolo, Andrea B

mRNA vaccine-induced antibodies more effective than natural immunity in neutralizing SARS-CoV-2 and its high affinity variants

mRNA疫苗诱导产生的抗体比自然免疫更能有效中和SARS-CoV-2及其高亲和力变异株。

Yu, Yunkai; Esposito, Dominic; Kang, Zhigang; Lu, Jianming; Remaley, Alan T; De Giorgi, Valeria; Chen, Leonard N; West, Kamille; Cao, Liang

Clinical characterization and cytokine profile of fatigue in hematologic malignancy patients with chronic graft-versus-host disease

慢性移植物抗宿主病血液系统恶性肿瘤患者疲劳的临床特征和细胞因子谱

Goklemez, Sencer; Saligan, Leorey N; Pirsl, Filip; Holtzman, Noa G; Ostojic, Alen; Steinberg, Seth M; Hakim, Frances T; Rose, Jeremy J; Kang, Zhigang; Yu, Yunkai; Cao, Liang; Mitchell, Sandra A; Im, Annie; Pavletic, Steven Z

Circulating Inflammation Proteins Associated With Lung Cancer in African Americans

非裔美国人肺癌相关的循环炎症蛋白

Meaney, Claire L; Mitchell, Khadijah A; Zingone, Adriana; Brown, Derek; Bowman, Elise; Yu, Yunkai; Wenzlaff, Angela S; Neslund-Dudas, Christine; Pine, Sharon R; Cao, Liang; Schwartz, Ann G; Ryan, Bríd M

Relationship between Circulating Inflammation Proteins and Lung Cancer Diagnosis in the National Lung Screening Trial

国家肺癌筛查试验中循环炎症蛋白与肺癌诊断的关系

Brown, Derek; Zingone, Adriana; Yu, Yunkai; Zhu, Bin; Candia, Julián; Cao, Liang; Ryan, Bríd M

Megakaryocyte Potentiating Factor as a Predictive Biomarker for Therapies Against Malignant Mesothelioma

巨核细胞增强因子作为恶性间皮瘤治疗的预测性生物标志物

Cao, Liang; Yu, Yunkai; Thomas, Anish; Zhang, Jingli; Onda, Masanori; Meltzer, Paul; Hassan, Raffit; Pastan, Ira